Takasato Minoru, Maier Barbara, Little Melissa H
Division of Molecular Genetics and Development, Institute for Molecular Biosciences, The University of Queensland, Brisbane, QLD, 4072, Australia.
Pediatr Nephrol. 2014 Apr;29(4):543-52. doi: 10.1007/s00467-013-2592-7. Epub 2013 Sep 13.
Access to human pluripotent cells theoretically provides a renewable source of cells that can give rise to any required cell type for use in cellular therapy or bioengineering. However, successfully directing this differentiation remains challenging for most desired endpoints cell type, including renal cells. This challenge is compounded by the difficulty in identifying the required cell type in vitro and the multitude of renal cell types required to build a kidney. Here we review our understanding of how the embryo goes about specifying the cells of the kidney and the progress to date in adapting this knowledge for the recreation of nephron progenitors and their mature derivatives from pluripotent cells.
从理论上讲,获取人类多能细胞可提供一种可再生的细胞来源,这些细胞能够分化为细胞治疗或生物工程所需的任何细胞类型。然而,对于包括肾细胞在内的大多数理想终末细胞类型而言,成功引导这种分化仍然具有挑战性。在体外鉴定所需细胞类型存在困难,且构建肾脏需要多种肾细胞类型,这使得这一挑战更加复杂。在此,我们回顾了我们对胚胎如何确定肾细胞的认识,以及迄今为止在将这些知识应用于从多能细胞重建肾祖细胞及其成熟衍生物方面所取得的进展。